Da Hee Hong

IL-7-primed bystander CD8 tumor-infiltrating lymphocytes optimize the antitumor efficacy of T cell engager immunotherapy

Yunji Park, N. Tae, Yeon-Woo Kang, 2024, Cell reports. Medicine.